Berberine
Berberine reduces blood sugar levels and improves insulin sensitivity in people with diabetes and prediabetes
Chromium Picolinate
Chromium picolinate enhances insulin function and helps regulate blood glucose metabolism
Effectiveness and Risk Overview
Condition | Effectiveness | Details |
|---|---|---|
| Type 2 Diabetes | Robust RCTs show berberine lowers HbA1c ~0.5% and fasting glucose; chromium improves insulin sensitivity; combined yields additive glucose control surpassing each alone. | |
| Metabolic Syndrome | Clinical trials demonstrate combined supplementation improves fasting glucose, triglycerides, and blood pressure, addressing core MetS criteria. | |
| Insulin Resistance | Meta‑analyses report chromium picolinate reduces HOMA‑IR modestly, berberine activates AMPK; together significantly improves cellular insulin response. | |
| Polycystic Ovary Syndrome (PCOS) | PCOS patients with insulin resistance benefit from berberine and chromium, showing reduced androgen levels and improved ovulatory function in RCTs. | |
| Obesity / Weight Management | Combined agents enhance glucose utilization and satiety, leading to modest (~3‑5%) body weight reduction in overweight adults over 12 weeks. |
